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Abstract 
Introduction or background: With a prevalence of 2-5%, amblyopia is the most common vision deficit in children 
in the UK and the second most common cause of functional low vision in children in low-income countries.  
Sources of data: Pubmed, Cochrane library and clinical trials registries (clinicaltrials.gov, ISRCTN, UKCRN 
portfolio database)  
Areas of agreement: Screening and treatment at the age of 4-5 years are cost efficient and clinically effective. 
Optical treatment (glasses) alone can improve visual acuity, with residual amblyopia treated by part-time occlusion or 
pharmacological blurring of the better seeing eye. Treatment after the end of the conventional “critical period” can 
improve vision, but in strabismic amblyopia carries a low risk of double vision. 
Areas of controversy: It is not clear whether earlier vision screening would be cost efficient and associated with 
better outcomes. Optimisation of treatment by individualised patching regimes or early start of occlusion, and novel 
binocular treatment approaches may enhance adherence to treatment, provide better outcomes and shorten treatment 
duration.  
Growing points: Binocular treatments for amblyopia. 
Areas timely for developing research: Impact of amblyopia on education and quality of life; optimal screening 
timing and tests; optimal administration of conventional treatments; development of child-friendly, effective and safe 
binocular treatments.  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Background 
What is amblyopia? 
Amblyopia (“lazy eye”) is the most common vision deficit in children, affecting 2-5% of children in the UK 1 2 and 
the second most common cause of functional low vision in children in low-income countries 3. Unilateral amblyopia 
is a developmental defect of vision, and has two main causes: 1) a difference in the optical properties of the two eyes, 
reflected in a different spectacle prescription for the right and the left eye (anisometropia), and 2) strabismus 
(misalignment of the visual axes) (Fig. 1). Some children have both anisometropic and strabismic amblyopia 
(“combined” or “mixed mechanism” amblyopia). Rarely, congenital or early childhood obstruction of the visual axis, 
for example by lid ptosis or by opacities of the cornea, crystalline lens or vitreous, can give rise to amblyopia by 
deprivation, as the retina does not receive a clear image. Deprivation amblyopia can affect both eyes. A high degree 
of refractive errors (long- or short-sightedness (hypermetropia/myopia), astigmatism) in both eyes can also cause 
bilateral amblyopia. 
 
 
Fig 1. Children with amblyopia can have straight eyes (left, anisometropic amblyopia), strabismus (strabismic amblyopia), or both. Small 
degrees of strabismus can go unnoticed and may only be discovered by orthoptic assessment (centre). In the UK, commissioning of vision 
screening at primary school entry is variable (right); commissioning in England has recently changed from Clinical Commissioning Groups to 
Local Authorities, resulting in boundary changes andfurther development of local protocols. An updated map is currently in preparation. Purple: 
pre-school orthoptic-led and delivered with orthoptic assessment, pre-school in community clinics; yellow: orthoptic-led and delivered with 
orthoptic assessment, in school at age 4-5 years; blue: orthoptic-led, other profession delivered,  visual acuity assessment in school at age 4-5 
years; green: other profession-led and delivered, visual acuity assessment onlyin school at age 4-5 years; blue: orthoptic-led visual acuity 
assessment only; red: no primary screening commissioned; white: unknown, no reponse to British and Irish Orthoptic Society questionnaire. 
 
Clinically, unilateral amblyopia is conventionally defined as a difference in best-corrected visual acuity (BCVA) 
between the two eyes of 0.20 logMAR (2 lines on an acuity chart, Fig. 2) 4. Best-corrected visual acuity is a measure 
of the smallest level of detail that can be resolved in an image, typically measured on a chart with letters or pictures of 
reducing size (optotypes) whilst wearing full spectacle correction. Smaller differences between the eyes (e.g. a 
difference of 0.10 logMAR) can be normal, as this is within typically measured levels of test-retest variability. 
Similarly, bilateral amblyopia is defined as a reduction of 0.20 logMAR or more compared with the developmental 
norms for BCVA at a given age – e.g. for four-year olds, a level of 0.10 logMAR is “normal” whereas six-year olds 
are expected to have a BCVA of 0.00 logMAR. For the purpose of treatment decisions, two levels of severity are 
distinguished: moderate amblyopia, with BCVA of the amblyopic eye of 0.60 logMAR or better, and severe 
amblyopia, with acuity worse than 0.60 logMAR.  
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Fig 2. LEFT: The visual acuity, measured on a logMAR chart, of an amblyopic eye is two or more lines (=0.20 logMAR, red line) less than the 
acuity in the better seeing eye (green line: 0.00 logMAR, normal visual acuity expected from the age of around 6 years on a crowded logMAR 
test). RIGHT: Here the reader can simulate the effects of amblyopic vision on acuity and crowding, using their peripheral vision. By fixating on 
the innermost grey cross in the top row, the isolated Landolt-C element should be reasonably identifiable. The effect of acuity losses can be 
experienced by fixating the increasingly distant crosses (though the magnitude of losses will depend on viewing distance). Fixating the crosses 
in the lower row allows visualisation of the effects of crowding. Here, the same Landolt-C is flanked to either side by ‘distractor’ elements. 
Where previously the isolated element was visible (e.g. when fixating the innermost cross), it should now be considerably more difficult to 
identify. Crowding can also be increased by fixating the more distant crosses and moving the central target further into peripheral vision. 
 
In unilateral amblyopia, the imbalanced input from the two eyes to the primary visual cortex causes deficits in visual 
processing. Because of this imbalance in image quality between the two eyes stereovision (3D vision) can be 
strongly reduced or even absent altogether, particularly in strabismus 5 6. This mismatch in image quality is also 
associated with a frequent suppression of the central part of the visual field of the amblyopic eye 7 (Fig. 2). In 
anisometropic amblyopia, there are additional reductions in contrast sensitivity, while strabismic amblyopia leads to a 
range of spatial disruptions including vulnerability to crowding in the central visual field, a difficulty identifying 
relevant information when it is surrounded by clutter 6, as well as perceptual distortions 8, and deficits in positional 
acuity, the ability to localise the relative position of an object in space. Higher-order deficits in eye-hand motor co-
ordination and global-motion processing have also been reported (reviewed in 9).  
 
A neural basis for these visual deficits is slowly beginning to emerge. Changes in the sensitivity of neurons in the 
primary visual cortex of the brain (V1) have been most extensively examined in this regard. There are suggestions 
that amblyopia causes ocular dominance preferences to be re-allocated from the amblyopic eye to the better-seeing 
eye, resulting in an under-representation of the amblyopic eye (reviewed in 5). In addition, anisometropia causes 
blurred vision in one eye and defocused input to the cortex, leading to suggestions that there is a selective loss of 
neurons sensitive to fine detail (high spatial frequencies) in the amblyopic eye. In strabismus, the misalignment of the 
visual axes also disrupts the input to binocular cortical neurons in V1, which only mature when receiving balanced 
input from both eyes. However, the observed magnitude of these physiological changes in V1 does not appear to 
wholly account for the magnitude of the sensory deficits described above. It is therefore likely that in addition to 
disturbances in V1 amblyopia also alters processing in extrastriate areas of the brain. 
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What is the “critical period”, and why does it matter?  
The development of the functional architecture of the visual cortex occurs in stages 10. The maturation phase is called 
the "critical period”; imbalance or disruption during this phase can profoundly alter the selectivity of neurons to 
visual input. Different aspects of visual processing have slightly different critical periods, though they may overlap. It 
was long thought that treatment for amblyopia was only possible during these early critical periods of visual 
development. However, newer observations have challenged the concept of a complete loss of plasticity in the visual 
processing areas even in adulthood, though the quality of plasticity in adulthood may differ from that in childhood. 
Recent reports indicate that suppression can be reversed and vision successfully improved even after the end of the 
conventional critical period, though early intervention delivers better outcomes (reviewed in 11, 12). 
 
Does amblyopia affect other aspects of life? 
The reduction in stereopsis can be associated with reduced fine and gross motor skills 13 14. Children treated for 
amblyopia may have lower social acceptance scores than their peers, and low self esteem, negative self image, 
feelings of depression, frustration, and embarrassment have been reported 15.  
 
What are the economical aspects? What is the burden of amblyopia for the individual, the family, and 
society? 
If amblyopia persists into adulthood, affected individuals may be unable to take up professions that require depth 
perception. Accidents affecting the better-seeing eye can lead to a loss of quality of life and independence; the 
estimated lifetime risk of bilateral visual impairment may be as high as 18%, compared with 10% for people without 
amblyopia 16. Recent utility analysis studies and systematic review found amblyopia screening and treatment to be 
cost effective, but dependent on the long-term utility effects of unilateral vision loss 1 17 18. 	
 
Aim of this review 
This review aims to provide an update e on clinical management of amblyopia in children, including an outlook on 
new treatment forms which may enter clinical practice over the next few years. 
 
Sources of data 
We searched Pubmed (http://www.ncbi.nlm.nih.gov/pubmed), the Cochrane Eyes and Vision Group Trials Register, 
the ISRCTN registry (www.isrctn.com/editAdvancedSearch), and ClinicalTrials.gov (www.clinicaltrials.gov). We 
did not use any date or language restrictions in the electronic searches. As this review is limited to 40 references, we 
narrowed our selection to work published between 2005 and 2015, then prioritized references based on the pyramid 
of evidence-based medicine, i.e. we first selected systematic reviews and reports of randomized clinical trials. For 
topic areas not covered by RCT evidence, we then selected case series and other publications of high quality. For the 
background section, we allowed important publications outside these limits. 
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Areas of agreement 
Treatment for strabismus has been attempted for hundreds of years, but surgical correction has only been practiced 
since 1839 19. It was soon observed that vision can be improved by straightening an amblyopic eye 19. Whilst glasses 
for presbyopia were first described at the end of the 13th century, and bifocal glasses were worn since the second half 
of the 18th century, refractive errors could only be accurately measured when the ophthalmoscope was invented in 
1850. Glasses for children were first dispensed at the end of the 19th century (Fig. 3). The first glasses for 
anisometropia are mentioned in 1913, though these were for adults who had undergone unilateral cataract extraction. 
However, glasses only came into wider use in the 1950s (personal communication from Neil Handley, Curator, 
British Optical Association Museum).  
 
 
Fig 3. In 1583, Bartisch documented the first conservative treatment of strabismus; in 1839, Dieffenbach first published a surgical method. 
Glasses for children were introduced at the end of the 19th century (images of spectacles courtesy of the College of Optometrists, London). 
Current amblyopia treatment includes glasses, occlusion or pharmacological blurring of the better seeing eye (atropine paralysis of the ciliary 
muscle/accommodation, with dilation of the pupil as associated effect), and occasionally strabismus surgery. Future treatment may involve 
binocular strategies balancing the input from the two eyes to the visual cortex. 
 
Over the past 15 years, a number of randomised controlled trials (RCT) have explored the role of glasses and 
patching in the treatment of amblyopia, and form the basis of today’s amblyopia management (Fig 4).  
The first step is the correction of any refractive error by prescribing glasses. This addresses both differences in 
refractive error between the two eyes (anisometropia) and high degrees of hypermetropia (longfar-sightedness) in 
both eyes, which can be a cause of strabismus. Only some children with amblyopia do not have significant refractive 
errors and will not benefit from glasses. This first phase is called “optical treatment” or “refractive adaptation”. Visual 
acuity typically improves over several months, with greatest improvement over the first few weeks of wearing 
glasses 11. Visual acuity in the amblyopic eye normalizes with glasses only in a fifth to a third of children 20 21, and no 
further treatment is needed. 
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A secondary form of treatment is started if the visual acuity in the amblyopic eye reaches a plateau and fails to 
improve further, with a persistent difference of 0.20 logMAR or more compared to the better-seeing eye or the level 
of visual acuity normal for the child’s age. Parents and carers are offered a choice between patching (occlusion) or 
blurring (pharmacological) treatment. The dose of occlusion depends on the severity of the residual amblyopia: two 
hours for moderate and six hours for severe amblyopia (reviewed in 11, 12, 22). If amblyopia persists after a period of 
two-hourly patching, a dose increase to six hours can improve visual acuity further 23. Other doses may be effective, 
but have not been tested in recent RCTs. Pharmacological blurring of the better seeing eye with one drop of G 
Atropine 1% twice a week can be used instead of patching. Children are monitored at eight- to twelve-weekly 
intervals until the visual acuity in the amblyopic eye has normalized, or until no further improvement is noted.  
Children who present or are referred late, after the end of the conventional “critical period” of visual development are 
typically offered these treatments after an informed discussion about the reduced treatment success rates in older 
children, and the increased risk of adverse events such as double vision 24.  
 
 
Fig 4. Current management of amblyopia in childhood (black) and areas of controversy (red). 
 
Can medication enhance outcomes in the treatment of older children with amblyopia? 
Certain neurotropic medicines such as levodopa enhance neural plasticity after the end of the critical period of vision 
development. However, Aa recent RCT found that levodopa does not enhance visual improvement in children age 7 
to 12 years with residual amblyopia after occlusion treatment 25. A phase I study of donezepil, a medication used in 
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Alzheimer disease, has not yet published results (NCT01584076). 
 
Areas of controversy 
In 2012, the Sight Loss and Vision Priority Setting Partnership asked patients, carers and eye health professionals to 
identify unanswered questions about the prevention, diagnosis and treatment of sight loss and eye conditions that 
they wished to see answered. 2,220 people responded to the survey. At workshops held in 2013 the top ten priorities 
for 12 categories of eye conditions were agreed. Two priorities concern amblyopia: “How do we improve screening 
and surveillance from the ante-natal period through to childhood to ensure early diagnosis of impaired vision and eye 
conditions?”, and “Can the treatment of amblyopia be improved to produce better short and long term outcomes than 
are possible with current treatments?” These and other questions remain important areas of both innovation and 
controversy (Fig. 4). 
 
Vision screening in childhood: when, and which tests? 
The two main factors underlying the development of amblyopia are strabismus and anisometropia. Children with 
anisometropia usually have “straight” eyes (Fig. 1), and their amblyopia can therefore go unnoticed until well after 
the critical period of visual development. Obvious Sstrabismus, on the other hand, is usually noticed early, but small 
degrees of strabismus may go unnoticed. In the UK, the National Screening Committee (NSC) recommends that all 
children should have an orthoptist-led screening assessment of their vision at the age of four to five years 
(http://legacy.screening.nhs.uk/vision-child). This recommendation is based on a review of currently available 
evidence, which indicates that optotype-based screening is the preferred screening method; most children are able to 
co-operate with this type of test by the age of four to five years. . This The current NSC recommendation means that 
whilst the screening assessment does not need to be carried out by orthoptists, staff delivering the program (school 
nurses, health technology care assistants or other health care professionals) should be trained, supervised, monitored 
and audited by orthoptists. However, in the UK commissioning of vision screening at primary school entry is 
variable (Fig. 1) 26. Screening is often also not universal, as “free” or “independent” school may not be included. 
From 2015, commissioning of vision screening in England has changed from Clinical Commissioning Groups to 
Local Authorities, resulting in boundary changes andfurther development of local protocols.  
 
The type of screening tests used also varies. Whilst assessment by an orthoptist may be the most reliable test 27, it is 
also the most expensivecost-effectiveness neds to be considered. Tests that involve the identification of letters 
(optotypes) are most reliable to detect vision deficits, but most children can only master these from the age of 4 years 
onwards. Accuracy of detection may be enhanced by the use of “crowded” as opposed to “single letter” acuity charts, 
i.e. the presentation of optotypes surrounded by other letters or flanking bars, and by additional tests, for example 
auto-refractors, which estimate the need for glasses, and can be applied to children at younger ages. However, 
published evidence about autorefractor accuracy in children is limited to hospital-based rather than population-based 
studies. A change in screening practice would be justified if earlier detection and treatment of amblyopia were to 
result in better outcomes. Current evidence is conflicting and of variable quality (reviewed in 18 28 29). A recently 
completed population-based vision screening study (Two large studies population-based are currently ongoing which 
will inform this debate: “Vision Screening for Amblyopia” (NCT01430247)) has enrolled 15,648 children aged 4 to 
4.5 years7,000 children in Zagreb to evaluate screening and treatmentthe efficacy of an optotype-based screening 
protocol and reported high testability, sensitivity and specificity 30, . and theAn ongoing population-based study, the 
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“Disinvestment Study of Population-Based Vision Screening in Children” (NCT01675193) in the Netherlands aims 
to determine the optimal screening intervals and cost-effectiveness of population-based vision screening in preverbal 
children.  
 
How does amblyopia affect education, activities of daily living, and quality of life? 
The effect of amblyopia on fine motor skills and confidence in social interactions is well known 13 14 15. Current work 
with children focuses on the educational impact, and has shown that children with amblyopia read more slowly 31. 
Previous studies did not demonstrate an effect of amblyopia on educational attainment, occupational status, and 
social functioning and quality of life (reviewed in 18 32). The ongoing study “Impact of amblyopia: reasons for not 
accessing treatment and the effect on developing literacy skills in young children” (UKCRN ID 16018) explores the 
educational impact in a cohort of 12,000 children as part of the “Born in Bradford” Project.  
 
What are the economical aspects? What is the burden of amblyopia for the individual, the family, and 
society? 
If amblyopia persists into adulthood, affected individuals may be unable to take up professions that require depth 
perception. Accidents affecting the better-seeing eye can lead to a loss of quality of life and independence; the 
estimated lifetime risk of bilateral visual impairment may be as high as 18%, compared with 10% for people without 
amblyopia 16. Recent utility analysis studies and systematic review found amblyopia screening and treatment to be 
cost effective, but dependent on the long-term utility effects of unilateral vision loss 1 17 18.  
 
Occlusion treatment: when to start, and how much, and when and how to stop? 
Previous RCTs have shaped the dosage regime of optical, occlusion and pharmacological blurring treatment. 
However, whilst studies evaluating optical treatment have shown that vision can gradually improve for several 
months after glasses have been started 33, many RCTs did not include a period of full refractive adaptation before 
starting a secondary treatment with patching or blurring. The question therefore arises whether early patching or 
blurring in addition to glasses would shorten overall treatment duration, possibly increasing adherence with treatment 
and clinic visits. The current “European Paediatric Amblyopia Treatment study for Children: Role of glasses wearing 
in amblyopia treatment” (EUPATCH, ISRCTN51712593) addresses this question. It is also not clear whether a 
shorter treatment duration and better adherence could be achieved by offering an individualized treatment approach, 
i.e. variable dosage schedules based on clinical findings, tolerance and dose response;, and this is the topic of the 
current RCT “Personalising dosing strategy for amblyopia treatment” (ISRCTN12292232).  Once visual acuity 
reaches a plateau and fails to improve further on two consecutive visits despite optimal treatment, occlusion or 
blurring treatment is stopped, typically by gradual tapering to reduce the risk of regression of the treatment effect. A 
recent study of 15 year old adolescents treated for amblyopia in childhood indicates that the treatment effect is 
maintained 34. However, even if regression occurs, visual acuity can often be regained should vision in the better 
seeing eye be reduced due to trauma or age-related degenerative changes. 
 
Surgical correction of strabismus: before, during or after amblyopia treatment? 
Many practitioners begin the management of strabismic amblyopia by first correcting any refractive error, then 
adding a secondary type of treatment (patching or blurring) if required, and finally deciding whether surgical 
correction of the strabismus would be beneficial. With glasses only, one study showed an improvement in amblyopic 
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eye visual acuity of 0.26 logMAR over 18 weeks, and resolution of amblyopia in a third of children; this was 
independent from any improvement in eye alignment 20. With this approach, the number of strabismus operations in 
the UK has been declining 35. However, some clinicians prefer to surgically align the eyes early in the management. 
No RCT evidence is available to inform whether one approach is superior to the other 36.  
 
Can medication enhance outcomes in the treatment of older children with amblyopia? 
Certain neurotropic medicines such as levodopa enhance neural plasticity after the end of the critical period of vision 
development. A recent RCT found that levodopa does not enhance visual improvement in children age 7 to 12 years 
with residual amblyopia after occlusion treatment 25. A phase I study of donezepil, a medication used in Alzheimer 
disease, has not yet published results (NCT01584076). 
 
Can treatments be developed that are more effective and more child-friendly than current treatments? 
The main drawbacks of occlusion and pharmacological blurring are poor adherence to treatment and suboptimal 
treatment outcomes. Lack of adherence to occlusion treatment is common. Patching the better-seeing eye may 
functionally incapacitate the child, and children often attempt to remove the patch. Adherence with occlusion is 
typically less than 50% of the prescribed dose 37, though educational interventions can increase the adherence rate for 
a twelve-week treatment period to 80% 38. Even with the best current treatment, only around half of children achieve 
near-normal visual acuity in the amblyopic eye. Around 25% of eyes with severe amblyopia and 58% of eyes with 
moderate amblyopia improve to a level of 0.20 logMAR or better with occlusion treatment over the first four months 
of treatment (reviewed in 11 12 22). After treatment is discontinued, visual acuity typically regresses, and a low-dose 
maintenance treatment is often used to 'wean' children off treatment. Two years after stopping treatment and at 15 
years of age, BCVA in the amblyopic eye is 0.20 logMAR worse than in the better-seeing eye in up to half of 
children 39 34.   Based on an increased understanding of the cortical processes underlying amblyopia, new treatment 
approaches have been developed. Most of these have been explored in prospective case series; some are currently 
being tested in randomized controlled trials. These new approaches are based on simultaneous binocular visual 
stimulation and aim to improve not only visual acuity in the amblyopic eye, but also to promote binocularity. At the 
same time, efforts are being made to make these treatments appealing to children. The following sections describe 
these approaches in more detail. 
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Growing points 
In amblyopia, the fastest area of growth in terms of publications per year, allocation of research grants and open 
randomized controlled trials is that of binocular treatment. These new methods involve playing computer games or 
watching movies on digital displays, with manipulation of the images shown to each eye by means of liquid crystal 
display (LCD) glasses or prism overlays. Presenting different images to each eye is called “dichoptic presentation”. 
To date, three systems have been used in children, albeit in case series only. The first system is known as “anti-
suppression therapy”, which focuses on the observation that the amblyopic eye has reduced contrast sensitivity 
relative to the better-seeing eye. In order to balance the cortical input and overcome the interocular suppression 
(reviewed in 5 7 40), images with reduced contrast are presented to the better-seeing eye, and images with higher 
contrast are shown to the amblyopic eye. The child then has to carry out a task that requires combination of the 
information from the two eyes. As performance improves, the image contrast shown to the better-seeing eye is 
gradually increased until contrast is equal for both eyes. A frequently used task is the Tetris game in which a series of 
falling blocks have to be fit together to form complete lines. The prescribed training dose is typically one to two 
hours a day. Improvement of visual acuity and binocular vision can occur within one to four weeks of training 7 41. A 
second treatment approach is “balanced binocular viewing (BBV)”, which blurs the image seen by the better-
seeing eye to achieve the same aim of balancing input to the primary visual cortex 42. The resolution of the image 
shown to the better seeing eye is matched to the resolution perceived by the amblyopic eye. Instead of playing a 
computer game, children watch movies at home for an hour a day while wearing LCD shutter glasses (Fig. 3).  A 
third method is the “Interactive binocular treatment (I-BiT™)“ system, which presents different parts of a two-
dimensional visual scene to either eye via shutter glasses, combined with a task that requires combination of the two 
images 43 44. Images are viewed with both eyes, but parts of the image can only be seen with the amblyopic eye. The 
material viewed consists of videos and interactive games.  Dichoptic treatments have so far only been used in 
prospective case series without control groups; RCTs are currently under way. The evaluation of results published so 
far is complicated by the use of different testing protocols, the enrolment of participants from different age groups, 
and those with and without prior treatment. However, the new treatments may be as effective as conventional 
patching or blurring treatment: with patching, visual acuity generally improves by around 0.22 logMAR over six 
months 34; across dichoptic treatment studies, acuity improvement ranges from 0.08 to 0.26 logMAR (reviewed in 
40). As dichoptic treatments balance the input to the primary visual cortex, they may also have a greater effect on 
binocular function than conventional treatments, as reflected in an improvement in stereoacuity in the range of 200 
seconds of arc (reviewed in 40).  In addition, binocular treatments may have advantages other than improvements in 
visual function. In particular, the use of computer games or videos in these approaches is likely to engage children’s 
attention and may thus improve adherence to treatment. Indeed, high adherence of 80.6 to 93% has been reported 
(reviewed in 40). Lastly, through treating the fundamental binocular imbalance of amblyopia, dichoptic approaches 
may reduce the recurrence of amblyopia after treatment is stopped. So far, recurrence of amblyopia after cessation of 
treatment is reportedly low, for example 0.055 logMAR at 10 weeks with I-BiT™ and 0.02 logMAR at 14 weeks 
with BBV, but long-term outcomes are unknown (reviewed in 40). 
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Areas timely for developing research 
With advances in research methods, including advances in functional magnetic resonance imaging and in 
psychophysical methodologies, amblyopia research is moving from studies mostly conducted with adult participants 
to studies involving children. The most innovative area of clinical research concerns the development and evaluation 
of binocular amblyopia treatments. In order to provide a robust evaluation of dichoptic treatments, three multicenter 
and one single-center randomized controlled trials are currently open to recruitment. The UK “interactive binocular 
treatment (iBiT™)” trial (NCT01702727) 44 randomizes children age 4-7 years to either playing an interactive 
computer game for 30 minutes once a week for six weeks with or without dichoptic presentation, or to watch a DVD 
using dichoptic image presentation, in a hospital setting. The Glasgow-based pilot trial “Perceptual learning in 
enhanced amblyopia treatment (PLEAT)” (ISRCTN14022536) involves playing a dichoptic contrast balancing game 
whilst wearing LCD shutter goggles. In New Zealand/Australia/Hong Kong/Singapore, the “Binocular Treatment of 
Amblyopia using Video games (BRAVO)” trial (ACTRN12613001004752) also uses a form of anti-suppression 
treatment, delivered as a Tetris game on an iPod touch, for children over the age of 7 years. Lastly, the US “Study of 
Binocular Computer Activities for Treatment of Amblyopia” (ATS18, NCT02200211) uses the Tetris game on an 
iPad in children age 5-17 years, with randomisation to either binocular game play for one hour a day or to occlusion 
treatment for two hours a day.  The acceptability of these treatments to children and families is still unknown. There 
are concerns that weekly hospital-based treatments will face problems with adherence, and families will find it 
difficult to attend frequent appointments. The Tetris game, whilst popular with adults, may be too repetitive to 
maintain a child’s attention for an hour a day over several weeks. Watching movies is therefore a treatment platform 
explored by several research teams 42 45; this requires modification of existing movies for graded 3D viewing. The 
spectrum of potential content is vast. Future studies will need to explore not only efficacy and safety, but also 
acceptability and usage.   
 
Glossary 
Anisometropia, a difference in the optical properties of both eyes, requiring different corrective lenses for the right 
and left eye 
BCVA, best corrected visual acuity 
Dichoptic, presenting images to each eye separately, viewing two images with each eye separately  
DVD, digital video disc  
LCD, liquid crystal display 
logMAR, logarithm of minimal angle of resolution, the current standard for measuring visual acuity on optotype 
charts. 
RCT, randomised controlled trial 
Strabismus, a misalignment of the visual axes UK, United Kingdom US, United States of America 
 
Funding 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Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of ophthalmology. The views 
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